177 related articles for article (PubMed ID: 28760893)
1. Fluconazole Pharmacokinetics in Galleria mellonella Larvae and Performance Evaluation of a Bioassay Compared to Liquid Chromatography-Tandem Mass Spectrometry for Hemolymph Specimens.
Astvad KMT; Meletiadis J; Whalley S; Arendrup MC
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760893
[TBL] [Abstract][Full Text] [Related]
2. Verapamil inhibits efflux pumps in
Vega-Chacón Y; de Albuquerque MC; Pavarina AC; Goldman GH; Mima EGO
Virulence; 2021 Dec; 12(1):231-243. PubMed ID: 33410730
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive approach for the detection of antifungal compounds using a susceptible strain of Candida albicans and confirmation of in vivo activity with the Galleria mellonella model.
Favre-Godal Q; Dorsaz S; Queiroz EF; Conan C; Marcourt L; Wardojo BP; Voinesco F; Buchwalder A; Gindro K; Sanglard D; Wolfender JL
Phytochemistry; 2014 Sep; 105():68-78. PubMed ID: 24984572
[TBL] [Abstract][Full Text] [Related]
4. Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents.
Li DD; Deng L; Hu GH; Zhao LX; Hu DD; Jiang YY; Wang Y
Biol Pharm Bull; 2013; 36(9):1482-7. PubMed ID: 23995660
[TBL] [Abstract][Full Text] [Related]
5. Antifungal effects of Streptococcus mutans extract on Candida strains susceptible and resistant to fluconazole: An in vivo study.
Alves MS; Fugisaki LRO; Dos Santos JD; Scorzoni L; Medina RP; Silva DHS; Junqueira JC
Med Mycol; 2021 Jul; 59(7):744-747. PubMed ID: 33594432
[TBL] [Abstract][Full Text] [Related]
6. Sensitive bioassay for determination of fluconazole concentrations in plasma using a Candida albicans mutant hypersusceptible to azoles.
Marchetti O; Majcherczyk PA; Glauser MP; Bille J; Moreillon P; Sanglard D
Antimicrob Agents Chemother; 2001 Mar; 45(3):696-700. PubMed ID: 11181345
[TBL] [Abstract][Full Text] [Related]
7. New antifungal 4-chloro-3-nitrophenyldifluoroiodomethyl sulfone reduces the Candida albicans pathogenicity in the Galleria mellonella model organism.
Staniszewska M; Gizińska M; Kazek M; de Jesús González-Hernández R; Ochal Z; Mora-Montes HM
Braz J Microbiol; 2020 Mar; 51(1):5-14. PubMed ID: 31486049
[TBL] [Abstract][Full Text] [Related]
8. Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model.
Andes D; van Ogtrop M
Antimicrob Agents Chemother; 1999 Sep; 43(9):2116-20. PubMed ID: 10471550
[TBL] [Abstract][Full Text] [Related]
9. Selective photoinactivation of Candida albicans in the non-vertebrate host infection model Galleria mellonella.
Chibebe Junior J; Sabino CP; Tan X; Junqueira JC; Wang Y; Fuchs BB; Jorge AO; Tegos GP; Hamblin MR; Mylonakis E
BMC Microbiol; 2013 Oct; 13():217. PubMed ID: 24083556
[TBL] [Abstract][Full Text] [Related]
10. Gentamicin synergises with azoles against drug-resistant Candida albicans.
Lu M; Yu C; Cui X; Shi J; Yuan L; Sun S
Int J Antimicrob Agents; 2018 Jan; 51(1):107-114. PubMed ID: 28943366
[TBL] [Abstract][Full Text] [Related]
11. Adaptation of a Gaussia princeps Luciferase reporter system in Candida albicans for in vivo detection in the Galleria mellonella infection model.
Delarze E; Ischer F; Sanglard D; Coste AT
Virulence; 2015; 6(7):684-93. PubMed ID: 26305489
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis.
Gonzalez JM; Rodriguez CA; Zuluaga AF; Agudelo M; Vesga O
PLoS One; 2015; 10(11):e0141872. PubMed ID: 26536105
[TBL] [Abstract][Full Text] [Related]
13. Galleria mellonella as a model for fungal pathogenicity testing.
Fallon J; Kelly J; Kavanagh K
Methods Mol Biol; 2012; 845():469-85. PubMed ID: 22328396
[TBL] [Abstract][Full Text] [Related]
14. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
15. Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.
Alobaid AS; Wallis SC; Jarrett P; Starr T; Stuart J; Lassig-Smith M; Mejia JL; Roberts MS; Sinnollareddy MG; Roger C; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2016 Nov; 60(11):6550-6557. PubMed ID: 27550344
[TBL] [Abstract][Full Text] [Related]
16. Assessment of in vivo antimicrobial activity of the carbene silver(I) acetate derivative SBC3 using Galleria mellonella larvae.
Browne N; Hackenberg F; Streciwilk W; Tacke M; Kavanagh K
Biometals; 2014 Aug; 27(4):745-52. PubMed ID: 25037059
[TBL] [Abstract][Full Text] [Related]
17. Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods.
Pascual A; Nieth V; Calandra T; Bille J; Bolay S; Decosterd LA; Buclin T; Majcherczyk PA; Sanglard D; Marchetti O
Antimicrob Agents Chemother; 2007 Jan; 51(1):137-43. PubMed ID: 17088483
[TBL] [Abstract][Full Text] [Related]
18. Studies on the role of insect hemolymph polypeptides: Galleria mellonella anionic peptide 2 and lysozyme.
Sowa-Jasiłek A; Zdybicka-Barabas A; Stączek S; Wydrych J; Mak P; Jakubowicz T; Cytryńska M
Peptides; 2014 Mar; 53():194-201. PubMed ID: 24472857
[TBL] [Abstract][Full Text] [Related]
19. Pre-exposure to yeast protects larvae of Galleria mellonella from a subsequent lethal infection by Candida albicans and is mediated by the increased expression of antimicrobial peptides.
Bergin D; Murphy L; Keenan J; Clynes M; Kavanagh K
Microbes Infect; 2006 Jul; 8(8):2105-12. PubMed ID: 16782387
[TBL] [Abstract][Full Text] [Related]
20.
Sheehan G; Tully L; Kavanagh KA
Microbiology (Reading); 2020 Apr; 166(4):375-385. PubMed ID: 32068530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
